insights_auto
Outlook: 49.2% bullish·3.0% bearish
Go to analysischevron_right
NVO:NYSE
Novo Nordisk A/S
$41.60
arrow_downward
-0.11%(-0.045) 1D
Nov 16, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 5 analysts giving stock ratings to NVO in the past 3 months
Hold
Buy
0
Hold
4
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVO in the last 3 months.
Highest
Current $41.60
$47.00 (+12.98%)
Average
$43.04 (+3.46%)
Lowest
$40.00 (-3.85%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Evan Seigerman BMO Capital | Hold | Reiterated | $44.00 | +5.8% | 11/05/2026 |
Kerry Holford Berenberg Bank | Hold | Maintained | $47.00 | +13% | 10/13/2026 |
Michael Nedelcovych TD Cowen | Hold | Maintained | $42.00 | +1% | 09/22/2026 |
Unknown Analyst Jefferies | Hold | Maintained | $42.20 | +1.4% | 09/22/2026 |
Thibault Boutherin Morgan Stanley | Sell | Downgraded | $40.00 | -3.8% | 09/11/2026 |
James Quigley Goldman Sachs | Hold | Maintained | $44.00 | +5.8% | 08/06/2026 |
Jasper Hellweg Argus Research | Hold | Maintained | - | - | 08/07/2026 |
Martin Brenoe Nordea Markets | Hold | Downgraded | - | - | 02/24/2026 |
Emmanuel Papadakis Deutsche Bank | Hold | Downgraded | - | - | 02/23/2026 |